Edition:
United States

Five Prime Therapeutics Inc (FPRX.OQ)

FPRX.OQ on NASDAQ Stock Exchange Global Select Market

9.64USD
14 Dec 2018
Change (% chg)

$-0.17 (-1.73%)
Prev Close
$9.81
Open
$9.75
Day's High
$10.25
Day's Low
$9.40
Volume
297,647
Avg. Vol
119,969
52-wk High
$23.27
52-wk Low
$9.40

Chart for

About

Five Prime Therapeutics, Inc. is a clinical-stage biotechnology company focused on discovering and developing protein therapeutics. The Company's product candidates include Cabiralizumab (FPA008), which is an antibody that inhibits colony stimulating factor-1 receptor, that it is studying in clinical trials as a monotherapy in... (more)

Overall

Beta: 4.21
Market Cap(Mil.): $1,122.56
Shares Outstanding(Mil.): 28.90
Dividend: --
Yield (%): --

Financials

  FPRX.OQ Industry Sector
P/E (TTM): -- 69.71 34.39
EPS (TTM): -4.24 -- --
ROI: -29.38 9.01 14.96
ROE: -31.27 10.15 16.52

Pharmacy benefit managers must face lawsuit over EpiPen prices - judge

Four pharmacy benefit managers must face a lawsuit alleging they breached their duties as administrators of employee health insurance plans' drug benefits by causing Mylan NV to raise the EpiPen allergy medication's price, a federal judge has ruled.

Oct 29 2018

Earnings vs. Estimates